0001209191-17-045599.txt : 20170718
0001209191-17-045599.hdr.sgml : 20170718
20170718193838
ACCESSION NUMBER: 0001209191-17-045599
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170714
FILED AS OF DATE: 20170718
DATE AS OF CHANGE: 20170718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Honig Peter
CENTRAL INDEX KEY: 0001484780
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33415
FILM NUMBER: 17970437
MAIL ADDRESS:
STREET 1: 3344 N. TORREY PINES COURT, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orexigen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001382911
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 651178822
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3344 N. TORREY PINES CT.
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 875-8600
MAIL ADDRESS:
STREET 1: 3344 N. TORREY PINES CT.
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-14
0
0001382911
Orexigen Therapeutics, Inc.
OREX
0001484780
Honig Peter
3344 NORTH TORREY PINES COURT
SUITE 200
LA JOLLA
CA
92037
1
0
0
0
Stock Option (Right to Buy)
2.88
2017-07-14
4
A
0
5000
0.00
A
2027-07-13
Common Stock
5000
5000
D
1/12th of the original number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest in equal monthly installments over 12 months following the vesting commencement date of July 14, 2017, subject to the Reporting Person's continuing service on the Issuer's Board of Directors through each such date, and subject to the terms of the Stock Option Agreement in the event of a change in control of the Issuer.
Thomas P. Lynch, Attorney-in-Fact for Peter K. Honig
2017-07-18